Jump Financial’s Upstream Bio UPB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.06M Sell
201,395
-21,828
-10% -$143K 0.01% 1342
2026
Q2
$1.54M Sell
223,223
-96,177
-30% -$806K 0.01% 995
2026
Q1
$2.87M Buy
+319,400
New +$5.75M 0.04% 527

Other funds holding UPB

Jump Financial's UPB Position: Q3 2026 in Review

Jump Financial reduced its Upstream Bio (UPB) stake by 9.8% in Q3 2026, selling an estimated $143K and leaving 201,395 shares worth $1.06M. The position accounts for 0.01% of the portfolio, ranked #1342.

Jump Financial first reported a position in UPB in Q1 2026 and has held it in 3 quarters since. The position peaked at $2.87M in Q1 2026. 135 funds tracked by Wall St. Rank hold UPB as of Q3 2026.

  • Jump Financial held 201,395 shares of Upstream Bio worth $1.06M as of Q3 2026.
  • Jump Financial sold 21,828 Upstream Bio shares in Q3 2026, an estimated $143K.
  • Upstream Bio made up 0.01% of Jump Financial's portfolio in Q3 2026, its #1342 holding.
  • Jump Financial first reported a position in Upstream Bio in Q1 2026 and has held it in 3 quarters since.
  • Jump Financial's Upstream Bio position peaked at $2.87M in Q1 2026.
  • 135 funds tracked by Wall St. Rank held Upstream Bio as of Q3 2026.

Based on Jump Financial's 13F filing for Q3 2026, filed 13 Nov 2026.